Sort
11,323 grants matching “glioblastoma”
Intracellular Host Tumor Responses to oHSVs and Avenues to Overcome These
$370,514E. Antonio Chiocca · Ohio State University · P01 · FY2015 · CA
Project 3: Strategies against radiation-induced cellular plasticity in glioblastoma
$370,368Frank Pajonk · University Of California Los Angeles · P50 · FY2022 · CA
Regulation of Asymmetric Cellular Division in Glioma Stem Cells
$370,339Daniel J Brat · Emory University · R01 · FY2012 · CA
X-ray/optical tomographic guidance and assessment for pre-clinical radiation research
$370,209Ken Kang-Hsin Wang · Johns Hopkins University · R37 · FY2019 · CA
Sub-component for Institution # 16-01848 Novel moleculary targeted therapy of GBM
$370,097Waldemar Debinski · Wake Forest University Health Sciences · P01 · FY2020 · CA
Improving glioma radiotherapy by theragnostic targeting of tumor-supporting macrophages
$369,981Matthew Scarpelli · Purdue University · R01 · FY2024 · NS
Decoding the molecular basis of cellular identity in adult malignant gliomas
$369,937Michael Clark Oldham · University Of California, San Francisco · R01 · FY2024 · CA
Establishing the Validity of Brain Tumor Perfusion Imaging
$369,886Christopher Chad Quarles · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Project 2: Analyses of the human GBM microenvironment form clinical trial specimens treated with the oncolytic HSV, rQNestin34v.2
$369,876E. Antonio Chiocca · Brigham And Women'S Hospital · P01 · FY2024 · CA
Therapeutic Targeting of Receptor Tyrosine Kinase Hierarchies in Schwann Cell Neoplasms
$369,821Steven L Carroll · Medical University Of South Carolina · R01 · FY2020 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$369,812Robert L Martuza · Massachusetts General Hospital · R01 · FY2016 · NS
Genetically Engineered Viruses for Brain Tumor Therapy
$369,812Robert L Martuza · Massachusetts General Hospital · R01 · FY2015 · NS
Clinical Relevance of Chromosome 5p/9p/20q/8q Germline Alterations in Glioma
$369,782Panagiotis Z Anastasiadis · Mayo Clinic Rochester · P50 · FY2014 · CA
Transcriptional Control of Human Cytomegalovirus Latency
$369,780Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2019 · AI
Transcriptional Control of Human Cytomegalovirus Latency
$369,780Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2021 · AI
Transcriptional Control of Human Cytomegalovirus Latency
$369,780Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2022 · AI
Transcriptional Control of Human Cytomegalovirus Latency
$369,780Robert F Kalejta · University Of Wisconsin-Madison · R01 · FY2020 · AI
Quantitative Analysis of Epidermal Growth Factor Receptor Signaling Networks
$369,511Forest M White · Massachusetts Institute Of Technology · R01 · FY2009 · CA
Development of a Novel Class of Highly Specific and Effective Oncolytic HSV Vect
$369,444Joseph C. Glorioso · Ohio State University · P01 · FY2017 · CA
Mitigation of preanalytic factors influencing brain tumor protein phosphorylation
$369,431Joanna Phillips · University Of California, San Francisco · U01 · FY2021 · CA
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$369,431Hideho Okada · University Of California, San Francisco · R01 · FY2020 · CA
Glioma immunotherapy targeting IDH mutation-derived epitope and immunosuppression
$369,431Hideho Okada · University Of California, San Francisco · R01 · FY2021 · CA
Physiologically Based Pharmacokinetic Modeling of Drug Penetration into the Human Brain and Brain Tumors
$369,429Jing Li · Wayne State University · R01 · FY2023 · CA
Eradication of Escaped Variant Tumor Cells for Cancer Immunotherapy
$369,383Yong Lu · Methodist Hospital Research Institute · R01 · FY2024 · CA
Cooperating Pathways in Gliomagenesis
$369,350Suzanne J Baker · St. Jude Children'S Research Hospital · R01 · FY2014 · CA